Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Palisade Bio Q3 EPS $(0.08) Down From $0.42 YoY

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.

Mizuho Maintains Buy on Alibaba Group Holding, Lowers Price Target to $280

By Benzinga Newsdesk

Today, 2:55 AM

Mizuho analyst James Lee maintains Alibaba Group Holding (NYSE:BABA) with a Buy and lowers the price target from $285 to $280.

BABA

Barclays Maintains Overweight on Chevron, Raises Price Target to $196

By Benzinga Newsdesk

Today, 2:55 AM

Barclays analyst Jeanine Wai maintains Chevron (NYSE:CVX) with a Overweight and raises the price target from $183 to $196.

CVX

New Oriental Sees Q1 Sales $641.3M-$680.6M vs $806.52M Est.

By Bill Haddad

Today, 2:55 AM

New Oriental expects total net revenues in the first quarter of the fiscal year 2023 (June 1, 2022 to August 31, 2022) to be in the range of US$641.3 million to US$680.6 million,

EDU